Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-219307
Filing Date
2020-08-14
Accepted
2020-08-13 17:53:31
Documents
9
Effectiveness Date
2020-08-14

Document Format Files

Seq Description Document Type Size
1 S-8 d10704ds8.htm S-8 74423
2 EX-5.1 d10704dex51.htm EX-5.1 11369
3 EX-23.1 d10704dex231.htm EX-23.1 1799
4 EX-99.1 d10704dex991.htm EX-99.1 74754
5 EX-99.2 d10704dex992.htm EX-99.2 75844
6 EX-99.3 d10704dex993.htm EX-99.3 49340
7 EX-99.4 d10704dex994.htm EX-99.4 50686
8 GRAPHIC g10704g43s57.jpg GRAPHIC 1594
9 GRAPHIC g10704m_smallemf.jpg GRAPHIC 3697
  Complete submission text file 0001193125-20-219307.txt   346779
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-245718 | Film No.: 201100500
SIC: 2835 In Vitro & In Vivo Diagnostic Substances